Aspira Pathlab P/E Ratio
Aspira Pathlab (ASPIRA) P/E ratio is 23.82 (Moderate), EPS (TTM) ₹1.97, current price ₹56.90 on BSE — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see ASPIRA stock live price.
Current P/E Ratio
23.82
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
23.82
Current Price
₹56.90
EPS (TTM)
₹1.97
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
61.88
Sector Median
40.64
Sector Rank
#11 of 47
Sector Percentile
23.4%
Earnings Breakdown (TTM)
TTM EPS
₹1.54
Mar 2025
₹0.66
Jun 2025
₹0.41
ASPIRA P/E Ratio — Valuation Signal & Historical Context
Aspira Pathlab P/E 23.82 — signal: Overvalued. Analyse Aspira Pathlab shareholding analysis to track promoter, FII and institutional holdings.
- Trading at discount to sector average PE of 61.88
ASPIRA vs Healthcare Services Peers — P/E Ratio Comparison
Aspira Pathlab P/E 23.82 vs Healthcare Services average 61.88, median 40.64 — range 6.55–408.11.
Sector Average
61.88
Sector Median
40.64
Lowest P/E
6.55
Highest P/E
408.11
Companies
47
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.55 | ₹99 | Low |
| Nidan Labs & Healthcare | NIDAN | 10.35 | ₹20 | Low |
| Deccan Health Care | DECCAN | 12.18 | ₹27 | Low |
| Shanmuga Hospital | SHANMUGA | 13.39 | ₹56 | Low |
| Abate AS Industries | ABATEAS | 17.43 | ₹182 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.73 | ₹1,045 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.94 | ₹1,165 | Moderate |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
| Clinitech Laboratory | CTLLAB | 20.81 | ₹8 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 21.56 | ₹4,024 | Moderate |